This is the web version of D.C. Diagnosis, STAT’s newsletter focusing on the intersection of health, politics, and policy, delivered twice a week. Sign up to get it in your inbox every Tuesday and Thursday.
We are pleased to introduce Margaret Manto, who will be covering the FDA. Additionally, we are excited to welcome back Nick Florko, the original creator of this newsletter in 2019. Nick also initiated STAT’s focus on the commercial determinants of health, and he will now be exploring a new area concerning the declining trust in science. For news tips or heartfelt reunions, reach out to [email protected] or contact John_Wilkerson.07 on Signal.
Generous Deadline Approaches for States
States have until Sept. 30 to decide on participating in a federal initiative that offers them “most-favored nation” pricing for drugs under Medicaid.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe
